A 12-year-old child with suspected von Willebrand's disease is being evaluated in the pediatric clinic. Which assessment finding would be most characteristic of this bleeding disorder?
The nurse is conducting an assessment of a child with suspected von Willebrand's disease.
1Petechiae on the lower extremities and trunk
2Deep muscle hematomas in the thighs and calves
3Hemarthrosis of the knee and elbow joints
4Prolonged bleeding after dental extraction and frequent nosebleeds✓ 정답
해설
Von Willebrand's disease is the most common inherited bleeding disorder, characterized by deficiency or dysfunction of von Willebrand factor, which is essential for platelet adhesion and aggregation. The hallmark clinical manifestations include mucocutaneous bleeding such as prolonged bleeding after dental procedures, frequent epistaxis (nosebleeds), and excessive menstrual bleeding in adolescent females.
Core Nursing ExplanationKey Concept Analysis: This question assesses the ability to differentiate the clinical presentation of von Willebrand disease (VWD) from other bleeding disorders. VWD is caused by a deficiency or dysfunction of von Willebrand factor (vWF), a protein that acts as a "glue" for platelets to adhere to damaged blood vessels and also carries and stabilizes clotting factor VIII. The primary defect is in primary hemostasis (platelet plug formation), leading to a characteristic pattern of bleeding.
Answer Rationale: Key Point! The most characteristic findings in VWD are mucocutaneous bleeding—bleeding from mucous membranes and skin surfaces. This is because vWF is critical for platelet adhesion under high shear stress, which is found in small vessels like those in the nose, gums, and skin. Therefore, a history of prolonged bleeding after dental extraction (a mucosal injury) and frequent nosebleeds (epistaxis) is classic for VWD. Menorrhagia (heavy menstrual bleeding) is also a hallmark in adolescent females.
Distractor Analysis:
Option 1 (Petechiae): Watch out for confusion! While petechiae (tiny red/purple spots from capillary bleeding) are a sign of bleeding disorders, they are more characteristic of thrombocytopenia (low platelet count) or platelet function defects. They can occur in severe VWD but are not the most classic or specific presentation.
Option 2 (Deep muscle hematomas): This is a hallmark of hemophilia (Factor VIII or IX deficiency), which affects secondary hemostasis (fibrin clot formation). Deep tissue bleeding into muscles and joints is more common in hemophilia due to the coagulation factor deficiency, not the primary platelet adhesion problem seen in VWD.
Option 3 (Hemarthrosis): This is the classic sign of severe hemophilia. Bleeding into joint spaces (like knees and elbows) causes pain, swelling, and can lead to chronic arthropathy. It is uncommon in most forms of VWD, except for the rare, severe Type 3 which also has very low Factor VIII levels.
Related Concepts: Understanding the difference between disorders of primary hemostasis (platelet/vWF problems) and secondary hemostasis (coagulation factor problems) is crucial. VWD primarily affects the first step. Laboratory findings in VWD typically show a prolonged bleeding time (assesses platelet function) and may show a prolonged activated partial thromboplastin time (aPTT) if Factor VIII levels are low.
Concept Summary
Disorder
Primary Defect
Characteristic Bleeding Pattern
Key Lab Findings
Von Willebrand Disease
vWF deficiency/dysfunction (Primary hemostasis)
Mucocutaneous: Nosebleeds, gum bleeding, heavy menses, prolonged bleeding after cuts or dental work.
Prolonged bleeding time, variable aPTT, low vWF antigen/activity.
Hemophilia A/B
Factor VIII or IX deficiency (Secondary hemostasis)
Deep tissue: Hemarthrosis, deep muscle hematomas, retroperitoneal bleeding.
Desmopressin (DDAVP) for mild types, vWF-containing concentrates
Recombinant Factor VIII or IX concentrates
Anatomy, Physiology & Pharmacology Points
Physiology: Von Willebrand factor is produced by endothelial cells and megakaryocytes. It has two key jobs: 1) It acts as a bridge between platelets and exposed collagen at a vessel injury site. 2) It binds to and stabilizes Factor VIII in the circulation, preventing its degradation.
Pharmacology: Desmopressin (DDAVP) is a synthetic analog of vasopressin that stimulates the release of vWF and Factor VIII from endothelial stores. It is a first-line treatment for many patients with mild Type 1 VWD before minor procedures.
Memory Tips
VWD = "Very Wet Disease": Think of bleeding from wet, mucosal surfaces (nose, mouth, GI tract, uterus).
Hemophilia = "Hard Hits": Think of deep, hard hits causing bleeding into joints and muscles.
Remember the triad for classic VWD presentation: Nosebleeds, Dental bleeding, Menorrhagia.
High-Frequency NCLEX Topics
The NCLEX frequently tests the ability to distinguish between different bleeding disorders based on clinical presentation. Be prepared to identify VWD by its mucocutaneous bleeding pattern and hemophilia by its deep tissue bleeding. Questions may also focus on patient education for managing bleeding risks and the nursing implications of administering treatments like DDAVP or factor concentrates.
Watch Out for Question Variations!
Instead of asking for the characteristic finding, a question might ask: "The nurse is preparing a child with von Willebrand's disease for a tonsillectomy. Which medication would the nurse anticipate administering preoperatively?" (Answer: Desmopressin/DDAVP or vWF concentrate).
A question could present lab values (e.g., prolonged bleeding time, normal platelet count) and ask you to identify the most likely disorder.
It might shift to a priority intervention: "A child with von Willebrand's disease has a nosebleed. Which action should the nurse take first?" (Answer: Apply direct, continuous pressure to the nostrils).
Nursing Clinical Practice GuideClinical Scenario: You are a nurse in a pediatric clinic. A 12-year-old boy, Michael, is brought in by his mother. She reports he has had frequent, hard-to-stop nosebleeds since he was a toddler and bled for over 3 hours after losing a baby tooth. He is scheduled for an elective dental filling next week, and the dentist requested a hematology evaluation.
Nursing Intervention Strategy:
Assessment: Conduct a thorough bleeding history. Use a tool like the ISTH-BAT (International Society on Thrombosis and Haemostasis Bleeding Assessment Tool). Ask specifically about: frequency/duration of nosebleeds, gum bleeding with brushing, bruising pattern, history of prolonged bleeding with cuts, surgeries, or dental work, and (for females) menstrual history. Inspect skin for bruises and petechiae.
Nursing Diagnosis & Planning: Risk for Injury (bleeding) related to impaired clotting mechanism. The plan includes educating the family on bleeding precautions and emergency management.
Implementation & Patient/Family Education:
Bleeding Precautions: Use a soft-bristle toothbrush, avoid contact sports (consider swimming, walking), use electric razors, avoid NSAIDs (like ibuprofen) which impair platelet function.
Managing Epistaxis: Teach to sit upright, lean forward slightly, pinch the soft part of the nose for 10-15 minutes continuously without releasing to check. Apply ice to the bridge of the nose.
Pre-procedure Management: Ensure coordination with the hematologist for potential pre-medication with DDAVP or factor concentrate before dental work.
Evaluation: Evaluate the family's understanding of home care and emergency plans. Monitor for any new or worsening bleeding episodes.
Patient Safety and Precautions:
Medication Alert: Aspirin and other NSAIDs are contraindicated as they can exacerbate bleeding. Acetaminophen is preferred for pain/fever.
DDAVP Administration: When given intravenously or subcutaneously, monitor for fluid retention and hyponatremia (especially in young children). Fluid intake may need to be restricted for 24 hours post-dose.
Emergency Preparedness: Families should have a written plan detailing when to seek emergency care (e.g., head injury, uncontrolled bleeding, severe abdominal pain which could indicate internal bleeding).
Verify the order, diagnosis, and indication (e.g., pre-prophylaxis for minor surgery).
Educate the patient/caregiver on proper administration: Insert the tip into one nostril, press the pump firmly once to deliver the dose. Do not sniff hard.
Instruct to administer the dose 1-2 hours before the procedure for peak effect.
Educate on signs of water intoxication (headache, nausea, vomiting, confusion, seizures) and the importance of limiting fluids after dose.
Document the administration and patient/caregiver comprehension.
A Word from Your Senior Nurse
"Remember, kids with bleeding disorders aren't fragile—they just need a different playbook. Your role is to empower them and their families with knowledge, not fear. In clinical practice, a detailed bleeding history is your most powerful diagnostic tool. When you hear 'frequent nosebleeds and heavy bleeding after dental work,' let von Willebrand disease pop into your mind immediately. Connecting that classic presentation to the underlying pathophysiology will make you a sharp clinician, whether you're facing an NCLEX question or a real patient in your clinic."
von Willebrand disease — The most common inherited bleeding disorder, caused by deficiency or dysfunction of von Willebrand factor, leading to impaired platelet adhesion and secondary Factor VIII deficiency.
Mucocutaneous bleeding — Bleeding from mucous membranes (nose, mouth, GI tract) and skin surfaces; the characteristic pattern in disorders of primary hemostasis like VWD.
Desmopressin — A synthetic vasopressin analog used to treat mild von Willebrand disease and mild hemophilia A by stimulating the release of stored vWF and Factor VIII from endothelial cells.
Hemarthrosis — Bleeding into a joint space; a classic manifestation of coagulation factor deficiencies like hemophilia, causing pain, swelling, and potential long-term joint damage.
Primary hemostasis — The initial phase of stopping bleeding, involving vasoconstriction and platelet plug formation at the site of vessel injury. Defects here (e.g., VWD, platelet disorders) cause mucocutaneous bleeding.